MiR-122 demonstrated a significantly increased expression in the ETC + C5/CD14 inhibition group compared to the ETC group and, although not significant, was also upregulated compared to the DCO group. This evidence concerns the gene CD14 and Leri-Weill dyschondrosteosis.